Form 4: Standex Director Sells Shares Under 10b5-1 Plan

Thomas E. Chorman, a Director at Standex International Corp., has sold 50 shares of common stock as part of a pre-arranged trading plan.

Summary

• Thomas E. Chorman, a Director of Standex International Corp., reported a transaction on June 1, 2026.
• The transaction involved the sale of 50 shares of common stock.
• This sale was executed under a Rule 10b5-1 trading plan established on November 6, 2025.
• The sale price was $272.82 per share.
• Following this transaction, Mr. Chorman beneficially owns 12,466 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale was conducted under a pre-established 10b5-1 plan, indicating it was planned in advance and not necessarily a reflection of negative sentiment towards the company.

Negatives

• A director has sold shares, which could be perceived negatively by the market, although it was part of a pre-planned strategy.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding future company performance. It solely reports a past transaction.

Industry Context

StockSavvy.ai notes that insider sales, particularly those executed under a Rule 10b5-1 plan, are common and often reflect personal financial planning rather than a negative outlook on the company's future. However, any significant insider selling can still attract market attention.

Stakeholder Impact

• Shareholders: May observe the sale as a minor reduction in insider ownership, but the pre-planned nature of the transaction under a 10b5-1 plan mitigates significant concern.
• Management: The transaction is a routine reporting event for directors and executives.

Key Dates

Keywords

Standex International Corp, SXI, Form 4, Insider Trading, 10b5-1 Plan, Stock Sale, Director Transaction, Beneficial Ownership